Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Mallinckrodt
Harvard Business School
Baxter
Express Scripts

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for BAUSCH HEALTH IRELAND LIMITED v. LUPIN INC. (D.N.J. 2019)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

BAUSCH HEALTH IRELAND LIMITED v. LUPIN INC. (D.N.J. 2019)

Docket   Start Trial Date Filed 2019-04-01
Court District Court, D. New Jersey Date Terminated
Cause 35:271 Patent Infringement Assigned To Renee Marie Bumb
Jury Demand Defendant Referred To Karen M. Williams
Parties BAUSCH HEALTH IRELAND LIMITED; LUPIN ATLANTIS HOLDINGS SA; LUPIN INC.; LUPIN LTD.; LUPIN PHARMACEUTICALS, INC.; NORGINE B.V.; SALIX PHARMACEUTICALS, INC.
Patents 10,016,504; 8,999,313; 9,326,969; 9,592,252; 9,707,297
Attorneys J. BRUGH LOWER; WILLIAM P. DENI , JR.
Link to Docket External link to docket
Small Molecule Drugs cited in BAUSCH HEALTH IRELAND LIMITED v. LUPIN INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for BAUSCH HEALTH IRELAND LIMITED v. LUPIN INC. (D.N.J. 2019)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 (“the ʼ252 patent”); 9,707,297 B2 (“the ʼ297 patent”); and 10,016,504 B2 (“the ʼ504 patent”) arising …United States Patent Nos. 8,999,313 B2 (“the ʼ313 patent”); 9,326,969 B2 (“the ʼ969 patent”); 9,592,252…the ’313 patent; claims 1–9 of the ’252 patent; claims 1–6, 8–18, and 20–24 of the ’297 patent; and claims… THE PATENTS IN SUIT 33. The U.S. Patent and Trademark Office (“PTO…PTO”) issued the ’313 patent on April 7, 2015. The ’313 patent claims, inter alia, compositions for admixture External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
McKinsey
Johnson and Johnson
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.